Viatris Stock

Viatris Net Margin

The Net Profit Margin of Viatris (VTRS) as of Aug 14, 2026 is -24.58 %. In the previous year, Net Profit Margin was -4.30 % — a change of 471.26% (lower).

Net Margin

-24.58 %

YoY

471.26%

Last updated:

Net Profit Margin of Viatris is 2026 -24.58 % . Net Profit Margin of Viatris was 2025 -4.30 % . It decreases by 471.26% lower compared to the previous year.

For Viatris, the net margin of -24.6% is down versus -7.1% a few years ago.

Access this data via the Eulerpool API

Viatris Stock analysis

What does Viatris do? Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide. Viatris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Viatris stock

Net Profit Margin of Viatris is -24.58 % in 2026.

Net Profit Margin of Viatris changed from -4.30 % to -24.58 %, representing a 471.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Viatris since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Viatris with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Viatris

All Key Metrics — Viatris